{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T06:04:42Z","timestamp":1780812282668,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T00:00:00Z","timestamp":1651449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00066-022-01951-0","type":"journal-article","created":{"date-parts":[[2022,5,2]],"date-time":"2022-05-02T11:02:56Z","timestamp":1651489376000},"page":"934-939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Stereotactic body radiotherapy for pulmonary oligometastases: a\u00a0monoinstitutional analysis of clinical outcomes and potential prognostic factors"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0390-9511","authenticated-orcid":false,"given":"Francesco","family":"Cuccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Mazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Figlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Giaj-Levra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ricchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Attin\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Pastorello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggero","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Alongi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,2]]},"reference":[{"issue":"5","key":"1951_CR1","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/BF00187656","volume":"6","author":"CJ Herold","year":"1996","unstructured":"Herold\u00a0CJ, Bankier\u00a0AA, Fleischmann\u00a0D (1996) Lung metastases. Eur Radiol 6(5):596\u2013606","journal-title":"Eur Radiol"},{"key":"1951_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman\u00a0S, Weichselbaum\u00a0RR (1995) Oligometastases. J\u00a0Clin Oncol 13:8\u201310","journal-title":"J Clin Oncol"},{"issue":"8","key":"1951_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.clon.2016.02.001","volume":"28","author":"AR Filippi","year":"2016","unstructured":"Filippi\u00a0AR, Guerrera\u00a0F, Badellino\u00a0S, Ceccarelli\u00a0M, Castiglione\u00a0A, Guarneri\u00a0A et\u00a0al (2016) Exploratory analysis on overall survival after either surgery or stereotactic radiotherapy for lung Oligometastases from colorectal Cancer. J\u00a0Clin Oncol 28(8):505\u2013512","journal-title":"J Clin Oncol"},{"issue":"2","key":"1951_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ijrobp.2014.10.021","volume":"91","author":"JJ Nuyttens","year":"2015","unstructured":"Nuyttens\u00a0JJ, van der Voort van Zyp\u00a0NC, Verhoef\u00a0C, Maat\u00a0A, van Klaveren\u00a0RJ, van der Holt\u00a0B et\u00a0al (2015) Stereotactic body radiation therapy for oligometastases to the lung: a\u00a0phase 2\u00a0study. Int J Radiat Oncol Biol Phys 91(2):337\u2013343","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1951_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11547-018-0858-7","volume":"123","author":"V Figlia","year":"2018","unstructured":"Figlia\u00a0V, Mazzola\u00a0R, Cuccia\u00a0F, Alongi\u00a0F, Mortellaro\u00a0G, Cespuglio\u00a0D, Cucchiara\u00a0T, Iacoviello\u00a0G, Valenti\u00a0V, Molino\u00a0M, Verderame\u00a0F, Matranga\u00a0D, Casto\u00a0AL, Ferrera\u00a0G (2018) Hypo-fractionated stereotactic radiation therapy for lung malignancies by means of helical tomotherapy: report of feasibility by a\u00a0single-center experience. Radiol Med 123(6):406\u2013414. https:\/\/doi.org\/10.1007\/s11547-018-0858-7","journal-title":"Radiol Med"},{"issue":"3","key":"1951_CR6","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.jgo.2019.05.002","volume":"11","author":"F Cuccia","year":"2020","unstructured":"Cuccia\u00a0F, Mortellaro\u00a0G, Mazzola\u00a0R, Donofrio\u00a0A, Valenti\u00a0V, Tripoli\u00a0A, Matranga\u00a0D, Casto\u00a0LA, Failla\u00a0G, Di Miceli\u00a0G, Ferrera\u00a0G (2020) Prognostic value of two geriatric screening tools in a\u00a0cohort of older patients with early stage Non-Small Cell Lung Cancer treated with hypofractionated stereotactic radiotherapy. J\u00a0Geriatr Oncol 11(3):475\u2013481. https:\/\/doi.org\/10.1016\/j.jgo.2019.05.002","journal-title":"J Geriatr Oncol"},{"key":"1951_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.10.023","author":"L Nicosia","year":"2021","unstructured":"Nicosia\u00a0L, Franceschini\u00a0D, Perrone-Congedi\u00a0F, Casamassima\u00a0F, Gerardi\u00a0MA, Rigo\u00a0M, Mazzola\u00a0R, Perna\u00a0M, Scotti\u00a0V, Fodor\u00a0A, Iurato\u00a0A, Pasqualetti\u00a0F, Gadducci\u00a0G, Chiesa\u00a0S, Niespolo\u00a0RM, Bruni\u00a0A, Alicino\u00a0G, Frassinelli\u00a0L, Borghetti\u00a0P, Di Marzo\u00a0A, Ravasio\u00a0A, De Bari\u00a0B, Sepulcri\u00a0M, Aiello\u00a0D, Mortellaro\u00a0G, Sangalli\u00a0C, Franceschini\u00a0M, Montesi\u00a0G, Aquilanti\u00a0FM, Lunardi\u00a0G, Valdagni\u00a0R, Fazio\u00a0I, Corti\u00a0L, Vavassori\u00a0V, Maranzano\u00a0E, Magrini\u00a0SM, Arcangeli\u00a0S, Valentini\u00a0V, Paiar\u00a0F, Ramella\u00a0S, Di Muzio\u00a0NG, Livi\u00a0L, Jereczek-Fossa\u00a0BA, Osti\u00a0MF, Scorsetti\u00a0M, Alongi\u00a0F (2021) A multicenter LArge retrospectIve daTabase on the personalization of Stereotactic ABlative Radiotherapy use in lung metastases from colon-rectal cancer: the LaIT-SABR study. Radiother Oncol. https:\/\/doi.org\/10.1016\/j.radonc.2021.10.023","journal-title":"Radiother Oncol"},{"issue":"4","key":"1951_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3978\/j.issn.2072-1439.2013.12.03","volume":"6","author":"D Singh","year":"2014","unstructured":"Singh\u00a0D, Chen\u00a0Y, Hare\u00a0MZ, Usuki\u00a0KY, Zhang\u00a0H, Lundquist\u00a0T, Joyce\u00a0N, Schell\u00a0MC, Milano\u00a0MT (2014) Local control rates with five-fraction stereotactic body radiotherapy for oligometastatic cancer to the lung. J\u00a0Thorac Dis 6(4):369\u2013374. https:\/\/doi.org\/10.3978\/j.issn.2072-1439.2013.12.03","journal-title":"J Thorac Dis"},{"issue":"25","key":"1951_CR9","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma\u00a0DA, Olson\u00a0R, Harrow\u00a0S, Gaede\u00a0S, Louie\u00a0AV, Haasbeek\u00a0C, Mulroy\u00a0L, Lock\u00a0M, Rodrigues\u00a0GB, Yaremko\u00a0BP, Schellenberg\u00a0D, Ahmad\u00a0B, Senthi\u00a0S, Swaminath\u00a0A, Kopek\u00a0N, Liu\u00a0M, Moore\u00a0K, Currie\u00a0S, Schlijper\u00a0R, Bauman\u00a0GS, Laba\u00a0J, Qu\u00a0XM, Warner\u00a0A, Senan\u00a0S (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J\u00a0Clin Oncol 38(25):2830\u20132838. https:\/\/doi.org\/10.1200\/JCO.20.00818","journal-title":"J Clin Oncol"},{"issue":"1","key":"1951_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0022-5223(97)70397-0","volume":"113","author":"U Pastorino","year":"1997","unstructured":"Pastorino\u00a0U, Buyse\u00a0M, Friedel\u00a0G, Ginsberg\u00a0RJ, Girard\u00a0P, Goldstraw\u00a0P, Johnston\u00a0M, McCormack\u00a0P, Pass\u00a0H, Putnam\u00a0JB Jr, International Registry of Lung Metastases (1997) Long-term results of lung metastasectomy: prognostic analyses based on 5206\u00a0cases. J\u00a0Thorac Cardiovasc Surg 113(1):37\u201349. https:\/\/doi.org\/10.1016\/s0022-5223(97)70397-0","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"4","key":"1951_CR11","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1093\/icvts\/ivz133","volume":"29","author":"S Li","year":"2019","unstructured":"Li\u00a0S, Nie\u00a0S, Li\u00a0Z, Che\u00a0G (2019) Is stereotactic radiotherapy equivalent to metastasectomy in patients with pulmonary oligometastases? Interact CardioVasc Thorac Surg 29(4):544\u2013550. https:\/\/doi.org\/10.1093\/icvts\/ivz133","journal-title":"Interact CardioVasc Thorac Surg"},{"issue":"2","key":"1951_CR12","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ijrobp.2017.06.130","volume":"99","author":"DP Lindsay","year":"2017","unstructured":"Lindsay\u00a0DP, Caster\u00a0JM, Wang\u00a0K, Myung\u00a0JH, Chen\u00a0RC, Chera\u00a0B et al (2017) Nanotechnology-based quantification of circulating tumor cells in oligometastatic patients undergoing definitive radiation therapy. Int J Radiat Oncol Biol Phys 99(2):S51","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1951_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13014-020-01491-w","volume":"15","author":"Y Zhao","year":"2020","unstructured":"Zhao\u00a0Y, Khawandanh\u00a0E, Thomas\u00a0S, Zhang\u00a0S, Dunne\u00a0EM, Liu\u00a0M, Schellenberg\u00a0D (2020) Outcomes of stereotactic body radiotherapy 60\u202fGy in 8 fractions when prioritizing organs at risk for central and ultracentral lung tumors. Radiat Oncol 15(1):61. https:\/\/doi.org\/10.1186\/s13014-020-01491-w","journal-title":"Radiat Oncol"},{"issue":"1","key":"1951_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.clon.2017.09.007","volume":"30","author":"GG Hanna","year":"2018","unstructured":"Hanna\u00a0GG, Murray\u00a0L, Patel\u00a0R et\u00a0al (2018) UK consensus on normal tissue dose constraints for stereotactic radiotherapy. Clin Oncol 30(1):5\u201314. https:\/\/doi.org\/10.1016\/j.clon.2017.09.007","journal-title":"Clin Oncol"},{"issue":"1051","key":"1951_CR15","doi-asserted-by":"publisher","first-page":"20150036","DOI":"10.1259\/bjr.20150036","volume":"88","author":"S Adebahr","year":"2015","unstructured":"Adebahr\u00a0S, Collette\u00a0S, Shash\u00a0E, Lambrecht\u00a0M, Le Pechoux\u00a0C, Faivre-Finn\u00a0C, De Ruysscher\u00a0D, Peulen\u00a0H, Belderbos\u00a0J, Dziadziuszko\u00a0R, Fink\u00a0C, Guckenberger\u00a0M, Hurkmans\u00a0C, Nestle\u00a0U (2015) LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a\u00a0clinical perspective. Br J Radiol 88(1051):20150036. https:\/\/doi.org\/10.1259\/bjr.20150036","journal-title":"Br J Radiol"},{"key":"1951_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-020-01627-7","author":"L Nicosia","year":"2020","unstructured":"Nicosia\u00a0L, Cuccia\u00a0F, Mazzola\u00a0R, Ricchetti\u00a0F, Figlia\u00a0V, Giaj-Levra\u00a0N, Rigo\u00a0M, Tomasini\u00a0D, Pasinetti\u00a0N, Corradini\u00a0S, Ruggieri\u00a0R, Alongi\u00a0F (2020) Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Strahlenther Onkol. https:\/\/doi.org\/10.1007\/s00066-020-01627-7","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"1951_CR17","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.ijrobp.2019.02.033","volume":"104","author":"C Greco","year":"2019","unstructured":"Greco\u00a0C, Pares\u00a0O, Pimentel\u00a0N, Louro\u00a0V, Morales\u00a0J, Nunes\u00a0B, Castanheira\u00a0J, Oliveira\u00a0C, Silva\u00a0A, Vaz\u00a0S, Costa\u00a0D, Zelefsky\u00a0M, Kolesnick\u00a0R, Fuks\u00a0Z (2019) Phenotype-oriented ablation of oligometastatic cancer with single dose radiation therapy. Int J Radiat Oncol Biol Phys 104(3):593\u2013603. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.02.033","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1951_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12885-020-06892-4","volume":"20","author":"GG Kalinauskaite","year":"2020","unstructured":"Kalinauskaite\u00a0GG, Tinhofer\u00a0II, Kufeld\u00a0MM, Kluge\u00a0AA, Gr\u00fcn\u00a0AA, Budach\u00a0VV, Senger\u00a0CC, Stromberger\u00a0CC (2020) Radiosurgery and fractionated stereotactic body radiotherapy for patients with lung oligometastases. BMC Cancer 20(1):404. https:\/\/doi.org\/10.1186\/s12885-020-06892-4","journal-title":"BMC Cancer"},{"issue":"1","key":"1951_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.21873\/anticanres.13965","volume":"40","author":"Y Niibe","year":"2020","unstructured":"Niibe\u00a0Y, Yamamoto\u00a0T, Onishi\u00a0H, Yamashita\u00a0H, Katsui\u00a0K, Matsumoto\u00a0Y, Oh\u00a0RJ, Aoki\u00a0M, Shintani\u00a0T, Yamada\u00a0K, Kobayashi\u00a0M, Ozaki\u00a0M, Manabe\u00a0Y, Yahara\u00a0K, Nishikawa\u00a0A, Kakuhara\u00a0H, Yamamoto\u00a0K, Inoue\u00a0T, Takada\u00a0YU, Nagata\u00a0K, Suzuki\u00a0O, Terahara\u00a0A, Jingu\u00a0K (2020) Pulmonary oligometastases treated by stereotactic body radiation therapy: a nationwide survey of 1,378 patients. Anticancer Res 40(1):393\u2013399. https:\/\/doi.org\/10.21873\/anticanres.13965","journal-title":"Anticancer Res"},{"issue":"6","key":"1951_CR20","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/jrr\/rraa071","volume":"61","author":"T Yamamoto","year":"2020","unstructured":"Yamamoto\u00a0T, Niibe\u00a0Y, Matsumoto\u00a0Y, Onishi\u00a0H, Aoki\u00a0M, Nishikawa\u00a0A, Oh\u00a0RJ, Shintani\u00a0T, Yahara\u00a0K, Ozaki\u00a0M, Manabe\u00a0Y, Jingu\u00a0K (2020) Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma. J\u00a0Radiat Res 61(6):935\u2013944. https:\/\/doi.org\/10.1093\/jrr\/rraa071","journal-title":"J Radiat Res"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-01951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-022-01951-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-022-01951-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:17:44Z","timestamp":1664277464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-022-01951-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,2]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s00066-022-01951-0","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,2]]},"assertion":[{"value":"20 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.\u00a0Cuccia, R.\u00a0Mazzola, V.\u00a0Figlia, N.\u00a0Giaj-Levra, L.\u00a0Nicosia, F.\u00a0Ricchetti, M.\u00a0Rigo, G.\u00a0Attin\u00e0, C.\u00a0Vitale, E.\u00a0Pastorello, R.\u00a0Ruggieri, and F.\u00a0Alongi declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}